BridgeMD
New treatment option for Hypertension
Official title Addressing Hypertension Care in Africa Program
ClinicalTrials.gov ID: NCT06986590
What this study is testing
- What it's testing
- The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model for improving hypertension control in Africa, which would ultimately reduce the risk of cardiovascular disease, stroke and kidney disease.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Aged 18 -70 years.
- Diagnosis of hypertension and elevated systolic blood pressure measure (≥140 mmHg) on the most recent clinic visit without a diabetes diagnosis.
- Hypertension treatment naive or on monotherapy.
- Receives primary care at one of the participating sites.
- Willing and able to provide informed consent in English, Twi, Dagbani, Ewe, Hausa, or Yoruba.
You likely can't join if
- Age \ 70 years.
- Severely elevated BP (≥180/110mmHg).
- Diagnosis of stroke, coronary artery disease, or kidney disease.
- Diagnosis of end-stage renal disease (ESRD) treated with dialysis.
- Serious medical condition which either limits life expectancy or requires active management (e.g., cancer).
- Cognitive impairment or other conditions preventing study participation
See the full eligibility criteria
- Aged 18 -70 years.
- Diagnosis of hypertension and elevated systolic blood pressure measure (≥140 mmHg) on the most recent clinic visit without a diabetes diagnosis.
- Hypertension treatment naive or on monotherapy.
- Receives primary care at one of the participating sites.
- Willing and able to provide informed consent in English, Twi, Dagbani, Ewe, Hausa, or Yoruba.
- Owns a smartphone (Android or iOS).
- Age \ 70 years.
- Severely elevated BP (≥180/110mmHg).
- Diagnosis of stroke, coronary artery disease, or kidney disease.
- Diagnosis of end-stage renal disease (ESRD) treated with dialysis.
- Serious medical condition which either limits life expectancy or requires active management (e.g., cancer).
- Cognitive impairment or other conditions preventing study participation
- Pregnant or currently nursing a child
- Unwilling to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Baltimore, Maryland, United States
- Bekwai, Ashanti Region, Ghana
- Kumasi, Ashanti Region, Ghana
- Tafo, Ashanti Region, Ghana
- Berekum, Bono, Ghana
- Duayaw Nkwanta, Bono, Ghana
- Tamale, Northern Region, Ghana
- Ho, Volta Region, Ghana
- Sogakope, Volta Region, Ghana
- Akure, Ondo State, Nigeria
- Ondo, Ondo State, Nigeria
- Owo, Ondo State, Nigeria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baltimore, Maryland, United States; Bekwai, Ashanti Region, Ghana; Kumasi, Ashanti Region, Ghana; Tafo, Ashanti Region, Ghana; Berekum, Bono, Ghana; Duayaw Nkwanta, Bono, Ghana and 6 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.